Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Jinsai Biotechnology is a high-tech enterprise specializing in the research, development, and manufacturing of high-end biological reagents and raw materials for the life sciences industry. Based in Jinan, China, the company focuses on the production of recombinant proteins, industrial enzymes, and diagnostic antigens and antibodies. Their flagship products include high-purity Proteinase K, Taq DNA polymerase, and reverse transcriptases, which are critical components for molecular diagnostics, including PCR and NGS workflows. The company operates under ISO 13485 quality management systems and serves a global clientele of diagnostic kit developers and biopharmaceutical companies. Shandong Jinsai's expertise in large-scale fermentation and protein purification allows them to provide scalable solutions for clinical and research applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Jinsai Biotechnology.